Commonly used drugs in hematologic disorders Journal Article

Local Library Link: Find It @ Loyola

Authors: Anderes, E.; Nand, S
Article Title: Commonly used drugs in hematologic disorders
Abstract: The drugs used to treat hematologic disorders constitute an extraordinary array of agents and include therapy for anemias, bleeding diatheses, thromboembolism and hematologic malignancies. Within many of these categories, hematologic therapies represent molecular understanding of the disease pathophysiology and a treatment targeted precisely at the known aberration. In this chapter we discuss these treatments, with greater emphasis on the most commonly used agents and the latest advances in the specific field. The chapter includes discussion on old (cyclooxygenase inhibitors) and new antiplatelet agents (ADP receptor P2Y12 inhibitors), newly described oral thrombin inhibitors such as dabigatran, treatment targeted at the bcr-abl tyrosine kinase in chronic myeloid leukemia and demethylating agents in myelodysplasia. The discussion is also oriented towards neurologic implications, both therapeutic and toxic, for each therapy or therapeutic group.
Journal Title: Handbook of clinical neurology
Volume: 120
ISSN: 0072-9752; 0072-9752
Publisher: Unknown  
Journal Place: Netherlands
Date Published: 2014
Start Page: 1125
End Page: 1139
Language: eng
DOI/URL:

10.1016/B978-0-7020-4087-0.00076-0

10.1016/B978-0-7020-4087-0.00076-0
Notes: CI: (c) 2014; JID: 0166161; OTO: NOTNLM; ppublish
LUC Authors
  1. Sucha Nand
    17 Nand
Related LUC Article